Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling.
Sci Signal. 2012 Jul 17; 5(233):ra50
Bryan Williams
18 Dec 2012
|
New Finding
This article raises an important issue about the potential side effects on the innate immune system of using agents targeting the epidermal growth factor receptor (EGFR) and src family tyrosine kinases for cancer therapy. In this paper, the authors make a substantial advance on some observations they published some years ago {1} describing...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.